Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · T. Rowe Price

T. Rowe Price Health Sciences Fund, Inc. T. Rowe Price Health Sciences Fund, Inc. (PRHSX)

Ticker PRHSX · Since 1995-12-29 · · Holdings as of Jun 30, 2026

Expense ratio
0.83%$83/yr per $10k
5-yr return
+4.2%annualized
1-yr return
+17.7%as of Dec 2025
Net assets
$11.9Ball share classes
Holdings
279

Bottom line

Is PRHSX a good fund? The bottom line

PRHSX is a share class of T. Rowe Price Health Sciences Fund, Inc., an actively managed health care sector mutual fund from T. Rowe Price.

Its expense ratio is 0.83% — about $83 a year on every $10,000 invested, cheaper than 59% of health care sector funds we track.

It returned +17.7% over one year, +4.2% a year over five years, +9.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $11.9 billion in net assets and 279 holdings, its largest position is Eli Lilly & Co (14.3%) and the top 10 make up 47.6% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 80% top-holdings overlap).

What stands out

  • Broadly diversified (279 holdings)
  • Large and established ($11.9 billion)

Updated Nov 19, 2026

What PRHSX invests in

The fund seeks long-term capital appreciation.

In the Summary Prospectus, and Sections 1 and 2 of the Prospectus, the disclosure under Principal Investment Strategies is supplemented as follows: The fund is nondiversified, which means it may invest a greater percentage of its assets in a particular issuer than is permissible for a diversified fund.

From the fund's prospectus (filed Jun 30, 2026).

PRHSX performance

Fund calendar-year total returns, 2016–2025 2016: −10.4%; 2017: +28.0%; 2018: +1.2%; 2019: +29.1%; 2020: +30.1%; 2021: +13.3%; 2022: −12.2%; 2023: +3.1%; 2024: +1.8%; 2025: +17.7% −10% 2016 +28% 2017 +1% 2018 +29% 2019 +30% 2020 +13% 2021 −12% 2022 +3% 2023 +2% 2024 +18% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PRHSX+17.7%+4.2%+9.1%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full PRHSX performance history →

What PRHSX costs

On a $10,000 investment, PRHSX's 0.83% expense ratio costs about $83 a year. The prospectus estimates $1,025 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full PRHSX fee table →

PRHSX top 10 holdings

#Holding% of fund
1Eli Lilly & Co14.28%
2Johnson & Johnson6.63%
3Unitedhealth Group Inc5.99%
4Abbvie Inc5.10%
5Merck & Co. Inc.4.01%
6Gilead Sciences Inc2.82%
7Thermo Fisher Scientific Inc2.52%
8Vertex Pharmaceuticals Inc2.28%
9Bristol-myers Squibb Co2.11%
10Abbott Laboratories1.89%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 47.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to PRHSX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%80% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%78% Compare
VanguardVHT Vanguard Health Care Index Fund0.09%79% Compare
iSharesIYH iShares U.S. Healthcare ETF0.37%77% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%58% Compare
SchwabSWHFX Schwab Health Care Fund0.8%73% Compare

More funds like PRHSX →

PRHSX FAQ

What is the expense ratio of PRHSX?
PRHSX's expense ratio is 0.83%, which works out to about $83 a year for every $10,000 invested. The prospectus estimates total costs of $1,025 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PRHSX a good investment?
It depends on your goals, but the data points to: broadly diversified (279 holdings); large and established ($11.9 billion). This is general information, not personalized advice.
What does PRHSX hold?
PRHSX's largest holdings are Eli Lilly & Co (14.3%), Johnson & Johnson (6.6%), Unitedhealth Group Inc (6.0%), Abbvie Inc (5.1%), Merck & Co. Inc. (4.0%). It holds 279 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is PRHSX's 5-year return?
PRHSX returned +4.2% a year over the five years ending Dec 31, 2025, and +9.1% a year over ten years. Past performance does not guarantee future results.
What is a cheaper alternative to PRHSX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 80% with PRHSX and charges 0.08%.
Who manages PRHSX?
PRHSX is offered by T. Rowe Price through T. Rowe Price Health Sciences Fund, Inc..